Related Experiment Video
Updated: Dec 13, 2025

04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
26.1K
Commentary: Leave Nothing Behind: No Stent, No Restenosis, No Mortality
Bhaskar Purushottam1, Joseph L Tuma1, Prakash Krishnan2
1Monument Health, Heart and Vascular Institute, Monument Health Rapid City Hospital, Rapid City, SD, USA.
Abstract
No abstract available in PubMed .
Related Concept Videos
Atherosclerosis III: Management
251
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
251
Coronary Artery Disease V: Interprofessional Care
163
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
163

